Veterinary Medicines

Gentaject vet. 100 mg/ml Injektionsvätska, lösning

Authorised
  • Gentamicin sulfate
Download as PDF

Product identification

Medicine name:
Gentaject vet. 100 mg/ml Injektionsvätska, lösning
Active substance:
  • Gentamicin sulfate
Target species:
  • Dog
  • Horse
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Gentamicin sulfate
    120.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Horse
      • All relevant tissues
        no withdrawal period
  • Subcutaneous use
    • Dog
    • Horse
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01GB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Franklin Pharmaceuticals Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Divasa Farmavic S.A.
  • Franklin Pharmaceuticals Limited
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 11836
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."